Effects of oral intake of hydrogen water on liver fibrogenesis in mice
Atsuko Yanagida, Esturo Hatano, Fujinawa, Gen Yamamoto, Hikohito Iwaisako, Hiromitsu Nagata, Kazutaka Tanabe, Keiko, Kenya Yamanaka, Koji Kitamura, Kojiro Nakamura, Kojiro Taura, Masato Narita, Shinji Uemoto, Taku Iida, Yukinori Koyama
Read more:
DOI:
10.1111/hepr.12165
DOI is the universal ID for this study.
This link will take you to the full study.
Abstract:
Aim: Liver fibrosis is the universal consequence of chronic liver diseases. Sustained hepatocyte injury initiates an inflammatory response, thereby activating hepatic stellate cells, the principal fibrogenic cells in the liver. Reactive oxygen species are involved in liver injury and are a promising target for treating liver fibrosis. Hydrogen water is reported to have potential as a therapeutic tool for reactive oxygen species-associated disorders. This study aimed to investigate the effects of hydrogen water on liver fibrogenesis and the mechanisms underlying these effects.
Methods: C57BL/6 mice were fed with hydrogen water or control water, and subjected to carbon tetrachloride, thioacetamide and bile duct ligation treatments to induce liver fibrosis. Hepatocytes and hepatic stellate cells were isolated from mice and cultured with or without hydrogen to test the effects of hydrogen on reactive oxygen species-induced hepatocyte injuries or hepatic stellate cell activation.
Results: Oral intake of hydrogen water significantly suppressed liver fibrogenesis in the carbon tetrachloride and thioacetamide models, but these effects were not seen in the bile duct ligation model. Treatment of isolated hepatocyte with 1 μg/mL antimycin A generated hydroxyl radicals. Culturing in the hydrogen-rich medium selectively suppressed the generation of hydroxyl radicals in hepatocytes and significantly suppressed hepatocyte death induced by antimycin A; however, it did not suppress hepatic stellate cell activation.
Conclusion: We conclude that hydrogen water protects hepatocytes from injury by scavenging hydroxyl radicals and thereby suppresses liver fibrogenesis in mice.
| Publish Year |
2014 |
| Country |
Japan |
| Rank |
Positive |
| Journal |
Hepatology Research |
| Primary Topic |
Liver |
| Secondary Topic | Liver Disease |
| Model |
Mouse |
| Tertiary Topic | Fibrosis |
| Vehicle |
Water (Dissolved) |
| pH |
Neutral |
| Application |
Ingestion |
| Comparison |
|
| Complement |
|
Hydrogen gas alleviates acute ethanol-induced hepatotoxicity in mice via modulating TLR4/9 innate ...
2023 - Liver - Fatty Liver Disease (Alcoholic)
Alcoholic liver disease (ALD), which is induced by chronic heavy alcohol consumption, accompanies complicated pathological mechanisms, including oxidative stress, inflammation, cell death, epigenetic changes and acetaldehyde-mediated toxicity. ...
Investigating the Effect of Hydrogen-Rich Water on Liver Cell Injury and Liver Cancer by Regulating ...
Background Liver cancer is an extremely heterogeneous malignant disease among tumors identified to date. In recent years, a large number of studies have found that low-concentration hydrogen or hydrogen-rich water or hydrogen-saturated physiological ...
The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q10 Levels and ...
2023 - Liver - Fatty Liver Disease (Nonalcoholic)
Molecular hydrogen (H2) has been recognized as a novel medical gas with antioxidant and anti-inflammatory effects. Non-alcoholic fatty liver disease (NAFLD) is a liver pathology with increased fat accumulation in liver tissue caused by factors other ...
Alleviating effects of hydrogen on hyperhomocysteinemia and fatty liver induced by high-methionine ...
2023 - Liver - Liver Disease
Objective: To investigate the alleviating effect of hydrogen (H2) on homocysteine (Hcy) levels and non alcoholic fatty liver in rats with hyperhomocysteinemia (HHcy). Methods: After one week of adaptive feeding, Wistar rats were randomly divided into ...
Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with ...
2023 - Liver - Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is a multisystem metabolic disease associated with gut microflora dysbiosis and inflammation. Hydrogen (H2) is a novel and effective antiinflammatory agent. The present study was aimed to clarify the effects ...
A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic ...
2022 - Liver - Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide with increasing incidence consistent with obesity, type 2 diabetes and cardiovascular diseases. No approved medication was currently available for NAFLD ...